Immunic
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -43 | -43 | |
EBITDA | -25,579 | -27,040 | -26,782 |
EBIT | -25,579 | -27,083 | -26,825 |
Net Income | -25,579 | -26,820 | -25,473 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -20,207 | -24,645 | -21,823 |
Cash | 35,132 | 55,310 | 14,304 |
Basic Shares | 193,897 | 132,175 | 101,344 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -134 | -111 | -77 |
EBITDA | -97,918 | -99,112 | -86,441 |
EBIT | -98,052 | -99,223 | -86,518 |
Net Income | -100,507 | -93,612 | -120,407 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | 20,875 | ||
Free Cash Flow | -85,030 | -71,162 | -65,256 |
Cash | 35,668 | 46,674 | 106,745 |
Basic Shares | 100,174 | 44,320 | 31,819 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.07 |
2025-09-30 | -$0.13 |
2025-06-30 | -$0.20 |
